DiaCarta, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity (NCT04580667) | DiaCarta, Inc. | 2020-10-01 |
Track DiaCarta, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.